Skip to content

Contact +44 (0) 20 7060 7474 email us

Management / Strategy

Maintaining a Competitive Edge in Pharmaceutical Public Affairs

Benchmarking the Resources Required to Serve the U.S. Market

Publication Date February 2008
Publisher Best Practices LLC
Product Type Report
Pages 48
ISBN Number not applicable
Product Code BPC00007

Price

£2,220.00
approximately: $3,361 | €2,478

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

STUDY OVERVIEW

To ensure organizational health and competitiveness, companies must continually identify optimal resource levels for their operations.

This benchmark study was designed to collect key staffing and investment benchmarks for U.S. based pharmaceutical Public Affairs functions.

Data from this study will allow U.S. pharmaceutical companies to assess the efficiency of their Public Affairs functions relative to their peers.

For the purposes of this benchmarking exchange, Public Affairs was divided into six work functions:

  • Government Affairs (State and Federal Government Relations and Public Policy)
  • Corporate Communications - External
  • Corporate Communication - Internal
  • Product Communications
  • Corporate Social Responsibility
  • Alliance Management

Note: Customized segmentation of the data is available for this report. For more information, call us on : +44 (0) 20 7060 7474

KEY TOPICS

  • Public Affairs: Structure and Reporting Relationships
  • Public Affairs: Staffing
  • Public Affairs: Investment
  • Public Affairs: Consolidated Staffing and Investment Efficiency Ratios
  • Lessons Learned

KEY METRICS

  • FTEs
  • Investment Levels
  • Budget per FTE
  • Budget per FTE adjusted for outsourcing
  • Budget as a percent of total revenue
  • Budget per U.S. Brand
  • Budget per U.S. Blockbuster Brand
  • FTEs per U.S. Brand
  • FTEs per U.S. Blockbuster Brand
  • Percent of Budget Outsourced
  • Public
  • Public Affairs FTEs per 1,000 Total Company Employees
  • Percent of Public Affairs Employees in Government Affairs
  • Percent of Public Affairs Employees in Corporate Communications - External
  • Percent of Public Affairs Employees in Corporate Communications - Internal
  • Percent of Public Affairs Employees in Product Communications
  • Percent of Public Affairs Employees in Corporate Social Responsibility
  • Percent of Public Affairs Employees in Alliance Management

METHODOLOGY
This research was based on survey results from 17 participants from 15 pharmaceutical and biotechnology companies.

Industries Profiled:

Consumer Products; Diagnostic; Pharmaceutical; Biotech; Health Care

Companies Profiled:

Bayer Healthcare; MedImmune; Cephalon; Inc. ; Eli Lilly and Company; Genentech; Genzyme; GlaxoSmithKline ; Merck; Novartis; Pfizer; Roche; Sanofi-Aventis; Solvay Pharmaceuticals; UCB Pharma; Wyeth Pharmaceuticals

Contents

  • Maintaining a Competitive Edge in Pharmaceutical Public Affairs: Benchmarking the Resources Required to Service the U.S. Market
  • STUDY OVERVIEW
    • Research Objective and Methodology
    • Benchmark Class
    • Benchmark Class Segmentation
    • Participant Qualification
    • Definitions
    • Response Rates by Work Function
    • Definitions Continued
  • PUBLIC AFFAIRS: STRUCTURE & REPORTING RELATIONSHIPS
    • Public Affairs Structure
    • Public Affairs Organizational Fit
    • Public Affairs Head - Scope of Responsibility
    • Public Affairs Head
    • Reporting Relationship of Public Affairs Head
    • Public Affairs Contribution
  • PUBLIC AFFAIRS STAFFING
    • FTE Allocation - Total Public Affairs Function
    • FTE Allocation - Government Affairs
    • FTE Allocation - Corporate Communications - External
    • FTE Allocation - Corporate Communications - Internal
    • FTE Allocation - Product Communications
    • FTE Allocation - Corporate Social Responsibility
    • FTE Allocation - Alliance Management
    • FTE Allocation - Other
  • PUBLIC AFFAIRS: INVESTMENT
    • Investment Allocation - Total Public Affairs Function
    • Investment Allocation - Government Affairs
    • Investment Allocation - Corporate Communications - External
    • Investment Allocation - Corporate Communications - Internal
    • Investment Allocation - Product Communications
    • Investment Allocation - Corporate Social Responsibility
    • Investment Allocation - Alliance Management
  • PUBLIC AFFAIRS: CONSOLIDATED INVESTMENT STAFFING AND INVESTMENT EFFICIENCY RATIOS
    • Ratio Definitions
    • Efficiency Ratios - Total Public Affairs Function
    • Efficiency Ratios - Government Affairs
    • Efficiency Ratios - Corporate Communications - External
    • Efficiency Ratios - Corporate Communications - Internal
    • Efficiency Ratios - Product Communications
    • Efficiency Ratios - Corporate Social Responsibility
    • Efficiency Ratios - Alliance Management
    • Efficiency Ratios - Percentages - Total Public Affairs
  • LESSONS LEARNED
    • Lessons from the Field
  • ABOUT BEST PRACTICES, LLC
Product Features / Use
Scope Expert Insight/Opinion
Level General Industry Strategies
Features Primary Research Data